Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 177

Sort by

Sort Order Select

Journal Articles

Role of NK cells in immune escape in patients with classical paroxysmal nocturnal hemoglobinuria

Chaomeng Wang, Yan Yang, Wei Wang, Liyan Li, Mengting Che, Yingying Chen, Honglei Wang, Zhaoyun Liu, Lijuan Li, Hui LIU, Rong Fu

Blood (2025) 146 (Supplement 1): 4664.

https://doi.org/10.1182/blood-2025-4664

Published: 2025

Journal Articles

Timed PD-1 blockade synergizes with IL-7/CCL19 armoring to reverse CAR-T exhaustion in PD-L1-high large B-cell lymphoma

Lixia Sheng, Wen Lei, Duo Wu, Yi Zhang, Yanli Lai, Shuyan Wang, Duobing Zou, Ping Zhang, Kaihong Xu, Shanhao Tang, Huijie Hu, Tongyu Li, Qitian Mu, Xiaofei Ye, Hui Liu, Wenbin Qian, Guifang Ouyang

Blood (2025) 146 (Supplement 1): 1929.

https://doi.org/10.1182/blood-2025-1929

Published: 2025

Journal Articles

Combination of mitoxantrone hydrochloride liposome with gemcitabine, cisplatin and dexamethasone (MGDP) in patients with relapsed or refractory peripheral T cell lymphoma: A prospective, single-arm, multicenter, Phase I/II study

Chong Wei, Yang Song, Shengyu Zhou, Shuangnian Xu, Hongmei Jing, Hui Liu, Wei Zhang, Dao-Bin Zhou

Blood (2025) 146 (Supplement 1): 5423.

https://doi.org/10.1182/blood-2025-5423

Published: 2025

Journal Articles

The role of neutrophil extracellular traps in thrombosis of paroxysmal nocturnal hemoglobinuria

Mengting Che, Hui LIU, Yan Yang, Chaomeng Wang, Liyan Li, Honglei Wang, Yingying Chen, Zhaoyun Liu, Lijuan Li, Rong Fu

Blood (2025) 146 (Supplement 1): 1112.

https://doi.org/10.1182/blood-2025-1112

Published: 2025

Journal Articles

Downregulation of TANK gene affects erythroid differentiation in PNH patients.

Liyan Li, Zewei Chen, Hui LIU, Zhaoyun Liu, Yingying Chen, Rong Fu

Blood (2025) 146 (Supplement 1): 1106.

https://doi.org/10.1182/blood-2025-1106

Published: 2025

Journal Articles

DYRK1A controls CD47 endocytic degradation and leukemia immune surveillance

Blood (2025) 146 (Supplement 1): 751.

https://doi.org/10.1182/blood-2025-751

Published: 2025

Journal Articles

Does intensive consolidation confer a clinical advantage over continued less intensive therapy in elderly patients with Acute Myeloid Leukemia in first remission following azacitidine plus venetoclax induction?

Blood (2025) 146 (Supplement 1): 5162.

https://doi.org/10.1182/blood-2025-5162

Published: 2025

Journal Articles

FOXO1⁺themis⁺ memory t cells underpin long-term remission after cytokine-armored CD19 CAR-t therapy in refractory lymphoma

Wenbin Qian, Aiqi Zhao, Hui Liu, Wen Lei, Minghuan Zhang, Tianshu Yu, Shuhan Zhong

Blood (2025) 146 (Supplement 1): 3707.

https://doi.org/10.1182/blood-2025-3707

Published: 2025

Journal Articles

The prognostic value of CAR-hematox in predicting toxic events in patients with relapsed refractory B cell lymphoma receiving 7x19 CAR-T treatment

Wenbin Qian, Panpan Chen, Hui Liu, Wen Lei

Blood (2025) 146 (Supplement 1): 7687.

https://doi.org/10.1182/blood-2025-7687

Published: 2025

Journal Articles

Iguratimod plus low-dose rituximab as second-line treatment in adults with primary immune thrombocytopenia: A multicenter, open-label, randomized, controlled, Phase 2 trial

Qiu-Sha Huang, Zhuo-Yu An, Peng Zhao, Qi Chen, Jin Wu, Hai-Xia Fu, Yujun Dong, Hongmei Jing, Liping Dou, Hui Liu, Yi Liu, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3044.

https://doi.org/10.1182/blood-2025-3044

Published: 2025

Journal Articles

Synergistic antitumor effects and mechanisms of KPT-330 combined with venetoclax in Acute Myeloid Leukemia

Yifan Liu, Weidong Ding, Xiaoya Yun, Hui Liu

Blood (2025) 146 (Supplement 1): 6104.

https://doi.org/10.1182/blood-2025-6104

Published: 2025

Journal Articles

Efficacy and Safety of cladribine combined with cytarabine and G-CSF in Eliminating Measurable Residual disease for Core-binding factor acute myeloid leukemia: A retrospective, single-arm, multicenter study

Qiuxiao Li, Xi Jia, Guopan Yu, Danian Nie, Ying Dong, Zhiqiang Sun, Chunju Wen, Jieyu Ye, Hui Liu, Hong Qu, Yu Zhang, Qifa Liu, Pengcheng Shi

Blood (2025) 146 (Supplement 1): 6968.

https://doi.org/10.1182/blood-2025-6968

Published: 2025

Journal Articles

Health-related quality of life in Chinese multiple myeloma patients treated with daratumumab-based regimens in real world: Exploratory analysis of the MMY4032

Luqun Wang, Wei Yang, Yafei Wang, Ting Niu, Rong Fu, Yuping Zhong, Wenbin Qian, Kaiyang Ding, Kai Sun, Hong Liu, Baijun Fang, Hui Liu, Yanhui Li, Yishen Yang, Jianmin Zhuo, Xi Chen, Jin Lu

Blood (2025) 146 (Supplement 1): 7529.

https://doi.org/10.1182/blood-2025-7529

Published: 2025

Journal Articles

Efficacy and safety of romiplostim N01 combined with cyclosporine in refractory aplastic anemia patients：a multicenter phase II study

Ting Wang, Lijuan Li, Huaquan Wang, Jia Song, Hui LIU, Yihao Wang, Liyan Li, Yue Ren, Rong Fu

Blood (2025) 146 (Supplement 1): 3195.

https://doi.org/10.1182/blood-2025-3195

Published: 2025

Journal Articles

Efficacy and safety of sorafenib combined with Standard Chemotherapy in adult patients with Myeloid sarcoma: A multi-center, cohort study

Qiuxiao Li, Xi Jia, Guopan Yu, Danian Nie, Ying Dong, Zhiqiang Sun, Chunju Wen, Jieyu Ye, Hui Liu, Hong Qu, Yu Zhang, Qifa Liu, Pengcheng Shi

Blood (2025) 146 (Supplement 1): 1670.

https://doi.org/10.1182/blood-2025-1670

Published: 2025

Journal Articles

Effectiveness and safety of polatuzumab vedotin in real-world clinical practice in Chinese patients with diffuse large B-cell lymphoma (POLAREAL): An interim analysis from a prospective, multicenter, observational registry study

Blood (2025) 146 (Supplement 1): 6293.

https://doi.org/10.1182/blood-2025-6293

Published: 2025

Journal Articles

The CDK7 inhibitor THZ1 overcomes venetoclax resistance in acute myeloid leukemia through dual regulation of p53 signaling and transcriptional networks

Weidong Ding, Xiaoya Yun, Yifan Liu, Hui Liu

Blood (2025) 146 (Supplement 1): 6796.

https://doi.org/10.1182/blood-2025-6796

Published: 2025

Journal Articles

CHN1 suppresses B-cell non-Hodgkin lymphoma progression via akt/mTOR pathway

Xiaoya Yun, Weidong Ding, Yifan Liu, Ru Feng, Jiangtao Li, Hui Liu

Blood (2025) 146 (Supplement 1): 6776.

https://doi.org/10.1182/blood-2025-6776

Published: 2025

Journal Articles

Is autologous hematopoietic stem cell transplantation as consolidation therapy superior to chemotherapy alone in newly diagnosed intermediate-high risk DLBCL patients?

Shuozi Liu, Lan Ma, Hui Liu, Jiefei Bai, Wenrong Huang, JunLi Chen, Li Bao, Shan Gao, Wanling Sun, Zhenling Li, Min Wang, Hongmei Jing

Blood (2025) 146 (Supplement 1): 1888.

https://doi.org/10.1182/blood-2025-1888

Published: 2025

Journal Articles

Increased EBV Infection and Relapse Rates Following Haploidentical Hematopoietic Cell Transplantation in the Era of Letermovir for Cytomegalovirus Prophylaxis: A Propensity Score Matching Analysis

Yifei Huang, Ren Lin, Shanyu Zhang, Zhiping Fan, Fen Huang, Li Xuan, Na Xu, Hui Liu, Zhixiang Wang, Min Dai, Hua Jin, Jing Sun, Qifa Liu

Blood (2024) 144 (Supplement 1): 4923.

https://doi.org/10.1182/blood-2024-202355

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Role of NK cells in immune escape in patients with classical paroxysmal nocturnal hemoglobinuria

Timed PD-1 blockade synergizes with IL-7/CCL19 armoring to reverse CAR-T exhaustion in PD-L1-high large B-cell lymphoma

Combination of mitoxantrone hydrochloride liposome with gemcitabine, cisplatin and dexamethasone (MGDP) in patients with relapsed or refractory peripheral T cell lymphoma: A prospective, single-arm, multicenter, Phase I/II study

The role of neutrophil extracellular traps in thrombosis of paroxysmal nocturnal hemoglobinuria

Downregulation of TANK gene affects erythroid differentiation in PNH patients.

DYRK1A controls CD47 endocytic degradation and leukemia immune surveillance

Does intensive consolidation confer a clinical advantage over continued less intensive therapy in elderly patients with Acute Myeloid Leukemia in first remission following azacitidine plus venetoclax induction?

FOXO1⁺themis⁺ memory t cells underpin long-term remission after cytokine-armored CD19 CAR-t therapy in refractory lymphoma

The prognostic value of CAR-hematox in predicting toxic events in patients with relapsed refractory B cell lymphoma receiving 7x19 CAR-T treatment

Iguratimod plus low-dose rituximab as second-line treatment in adults with primary immune thrombocytopenia: A multicenter, open-label, randomized, controlled, Phase 2 trial

Synergistic antitumor effects and mechanisms of KPT-330 combined with venetoclax in Acute Myeloid Leukemia

Efficacy and Safety of cladribine combined with cytarabine and G-CSF in Eliminating Measurable Residual disease for Core-binding factor acute myeloid leukemia: A retrospective, single-arm, multicenter study

Health-related quality of life in Chinese multiple myeloma patients treated with daratumumab-based regimens in real world: Exploratory analysis of the MMY4032

Efficacy and safety of romiplostim N01 combined with cyclosporine in refractory aplastic anemia patients：a multicenter phase II study

Efficacy and safety of sorafenib combined with Standard Chemotherapy in adult patients with Myeloid sarcoma: A multi-center, cohort study

Effectiveness and safety of polatuzumab vedotin in real-world clinical practice in Chinese patients with diffuse large B-cell lymphoma (POLAREAL): An interim analysis from a prospective, multicenter, observational registry study

The CDK7 inhibitor THZ1 overcomes venetoclax resistance in acute myeloid leukemia through dual regulation of p53 signaling and transcriptional networks

CHN1 suppresses B-cell non-Hodgkin lymphoma progression via akt/mTOR pathway

Is autologous hematopoietic stem cell transplantation as consolidation therapy superior to chemotherapy alone in newly diagnosed intermediate-high risk DLBCL patients?

Increased EBV Infection and Relapse Rates Following Haploidentical Hematopoietic Cell Transplantation in the Era of Letermovir for Cytomegalovirus Prophylaxis: A Propensity Score Matching Analysis

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only